Drug screen and machine learning predict neuroprotective agents in a preclinical human model of childhood dementia药物筛选和机器学习预测预临床儿童痴呆模型中的神经保护剂Nature CommunicationsIF15.72026-08-200OAAI
Evaluation of neuroretina following i.v. or intra-CSF AAV9 gene replacement in mice with MPS IIIA, a childhood dementiaCNS NEUROSCIENCE & THERAPEUTICSIF52024-08-090OAAI
Superior outcomes in neuroretina following IV versus intra-CSF AAV9 gene replacement in mice with MPS IIIAMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment postureNEUROPATHOLOGY AND APPLIED NEUROBIOLOGYIF3.42013-09-099PREAI
Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: Inhibition by NSAIDsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32009-09-0760OAAI
Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data:: the effect of fluconazole on zidovudine glucuronidationBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32006-02-02156OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向